Summary

Psychedelics are a class of compounds that alter people's perceptions, mood and mental processes. Recent clinical studies suggest that some of these compounds, such as lysergic acid diethylamide (LSD) and psilocybin, could be promising for the treatment of depression and other psychiatric disorders. Despite these encouraging results, the molecular and neural processes via which they could improve psychiatric symptoms remain poorly understood. Delineating these processes could inform future clinical studies and potentially help to devise more effective psychedelic treatments.

AI summaries can be wrong sometimes—always verify important details using the source article.